Nutrition-related studies involving sickle cell disease (SCD) patients, particularly those in Africa.
BioNTech partners with Autolus to advance CAR-T therapies
Share this article BioNTech intends to commence ten registrational clinical trials, including the BNT211 programme by the end of 2024. Credit: dayandnightcollective / Shutterstock.com. BioNTech